DEVELOPMENT AND EVALUATION OF METFORMIN TABLETS: EFFECT OF SUPERDISINTEGRANTS-Reference-Cited by-同舟云学术

DEVELOPMENT AND EVALUATION OF METFORMIN TABLETS: EFFECT OF SUPERDISINTEGRANTS

Published:2024-03-28 Issue:03 Volume:61 Page:21-24
ISSN:0019-462X
Container-title:INDIAN DRUGS
language:
Short-container-title:IND. DRU.

Author:

,Veintramuthu Sankar,Annamalai Giridharan,Shikkandar Ashma

Abstract

Metformin is an oral antihyperglycemic medication used to treat type 2 diabetes. BCS-III classification of medications includes metformin hydrochloride, which has a high solubility and a low permeability. This study’s objective was to develop wet granulated metformin hydrochloride tablets using various synthetic superdisintegrants. On disintegration and dissolution, the effects of different superdisintegrants have been studied. After evaluation, it were observed that post-compression properties such as weight variability, thickness, hardness, and friability were within the IP ranges. The formulation F4 with Croscarmellose sodium (CCS) in low concentration was chosen as the best formulation. By increasing the quantity of Croscarmellose sodium (CCS), the in vitro dissolution profile increased, and in vitro disintegration time also increased in the formulated tablets using wet granulation method. The statistical significance was determined using one-way ANOVA, and there is no significant difference between formulations.

Publisher

Indian Drug Manufacturers' Association (IDMA)

Link

https://www.indiandrugsonline.org//download/March_2024_61_3_21-24.pdf

Reference5 articles.

1. 1. Modi, A., Pandey, A., Singh, V., Bonde, C. G., Jain, D., & Shinde, S. Formulation and evaluation of fast dissolving tablets of diclofenac sodium using different superdisintegrants by direct compression method. Pharmacia, 2012, 1(3) 95-101.

2. 2. Voleti, V. K., Gunasekharan, V., Bolla, S. P., Kumar, J. M., & Rayaprolu, M. Formulation and evaluation of Levo cetirizine dihydrochloride fast dissolving tablets using superdisintegrants. Int. J. Pharm Pharm Sci, 2010, 5 324-328.

3. 3. Mohanachandran, P. S., Sindhumol, P. G., & Kiran, T. S.). Superdisintegrants: an overview. Int. J. Pharm. Sci. Rev.Res, 2011, 6(1)105-109.

4. 4. Yassin, S., Goodwin, D. J., Anderson, A., Sibik, J., Wilson, D. I., Gladden, L. F., & Zeitler, J. A. (. The disintegration process in microcrystalline cellulose-based tablets, part 1: influence of temperature, porosity and superdisintegrants. J. pharm.sci, 2015, 104(10)3440-3450.

5. 5. Battu, S. K., Repka, M. A., Majumdar, S., & Rao Y, M.. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug dev. Ind. Pharm, 2007, 33(11)1225-1232.